Davide Placido
Research Subjects
Research Interests
Davide Placido has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Bône
Guerbet Research, Villepinte, France
1 shared publication - Clément Abi Nader
Université Côte d'Azur Inria Sophia Antipolis Epione Research Project France
1 shared publication - Federico De Masi1 shared publication
- Laura Degand
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (L.D., D.P., P.C., S.B.); Guerbet Research, Villepinte, France (C.A.N., A.B., R.V., M.M.R.); Department of Health Technology, Technical University of Denmark (DTU), Kongens Lyngby, Denmark (F.D.M.).
1 shared publication - Marc-Michel Rohé
Guerbet Research
1 shared publication - Piotr Jaroslaw Chmura
Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
1 shared publication
Latest Publications
- Open Access
- 24 June 2025
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 61 (2) , 75-83
Validation of a Pretrained Artificial Intelligence Model for Pancreatic Cancer Detection on Diagnosis and Prediagnosis Computed Tomography Scans
Purpose: To evaluate PANCANAI, a previously developed AI model for pancreatic cancer (PC) detection, on a longitudinal cohort of patients. In particular, aiming for PC detection on scans acquired before histopathologic diagnosis was assessed. Materials and Methods: The model has been previously trained to predict PC suspicion on 2134 portal venous CTs. In this study, the algorithm was evaluated on a retrospective cohort of Danish patients with biopsy-confirmed PC and with CT scans acquired between 2006 and 2016. The sensitivity was measured, and bootstrapping was performed to provide median and 95% CI. Results: The study included 1083 PC patients (mean age: 69 y ± 11, 575 men). CT scans were divided into 2 groups: (1) concurrent diagnosis (CD): 1022 CT scans acquired within 2 months around histopathologic diagnosis, and (2) prediagnosis (PD): 198 CT scans acquired before histopathologic diagnosis (median 7 months before diagnosis). The sensitivity was 91.8% (938 of 1022; 95% CI: 89.9–93.5) and 68.7% (137 of 198; 95% CI: 62.1–75.3) on the CD and PD groups, respectively. Sensitivity on CT scans acquired 1 year or more before diagnosis was 53.9% (36 of 67; 95% CI: 41.8–65.7). Sensitivity on CT scans acquired at stage I was 82.9% (29 of 35; 95% CI: 68.6–94.3). Conclusion: PANCANAI showed high sensitivity for automatic PC detection on a large retrospective cohort of biopsy-confirmed patients. PC suspicion was detected in more than half of the CT scans that were acquired at least a year before histopathologic diagnosis.
- 24 June 2025
- Published by Wolters Kluwer Health in Investigative Radiology
- Vol. 61 (2) , 75-83
Open AccessValidation of a Pretrained Artificial Intelligence Model for Pancreatic Cancer Detection on Diagnosis and Prediagnosis Computed Tomography Scans
Purpose: To evaluate PANCANAI, a previously developed AI model for pancreatic cancer (PC) detection, on a longitudinal cohort of patients. In particular, aiming for PC detection on scans acquired before histopathologic diagnosis was assessed. Materials and Methods: The model has been previously trained to predict PC suspicion on 2134 portal venous CTs. In this study, the algorithm was evaluated on a retrospective cohort of Danish patients with biopsy-confirmed PC and with CT scans acquired between 2006 and 2016. The sensitivity was measured, and bootstrapping was performed to provide median and 95% CI. Results: The study included 1083 PC patients (mean age: 69 y ± 11, 575 men). CT scans were divided into 2 groups: (1) concurrent diagnosis (CD): 1022 CT scans acquired within 2 months around histopathologic diagnosis, and (2) prediagnosis (PD): 198 CT scans acquired before histopathologic diagnosis (median 7 months before diagnosis). The sensitivity was 91.8% (938 of 1022; 95% CI: 89.9–93.5) and 68.7% (137 of 198; 95% CI: 62.1–75.3) on the CD and PD groups, respectively. Sensitivity on CT scans acquired 1 year or more before diagnosis was 53.9% (36 of 67; 95% CI: 41.8–65.7). Sensitivity on CT scans acquired at stage I was 82.9% (29 of 35; 95% CI: 68.6–94.3). Conclusion: PANCANAI showed high sensitivity for automatic PC detection on a large retrospective cohort of biopsy-confirmed patients. PC suspicion was detected in more than half of the CT scans that were acquired at least a year before histopathologic diagnosis.